A panel discussion exploring the future of drug development and the Food and Drug Administration – reimagined. The session will discuss how the patient voice has historically shaped rare disease drug development, what obstacles patients continue to face in clinical trial participation and beyond, and how patient advocates can come together to reimagine and reshape the FDA to reduce the burden on patients and speed up the drug development process.